SIC
Starr International Company Portfolio holdings
AUM
$19.9M
This Quarter Return
+0.04%
1 Year Return
-39.69%
3 Year Return
-26.08%
5 Year Return
-43.79%
10 Year Return
-39.24%
AUM
$22.4M
AUM Growth
+$22.4M
(+70%)
Cap. Flow
+$9.97M
Cap. Flow
% of AUM
44.56%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
2
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
AstraZeneca
AZN
|
$5.1M |
| 2 |
Moderna
MRNA
|
$4.74M |
| 3 |
Bain Capital Specialty
BCSF
|
$139K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 57.24% |
| 2 | Financials | 42.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Bain Capital Specialty
BCSF
$1.03B
| $7.66M | 34.19% | 750,462 +13,589 | +2% | +$139K |
|
|
2
AstraZeneca
AZN
$248B
| $5.1M | 22.76% | +93,000 | New | +$5.1M |
|
|
3
Moderna
MRNA
$9.37B
| $4.74M | 21.17% | +67,000 | New | +$4.74M |
|
4
Johnson & Johnson
JNJ
$427B
| $2.98M | 13.3% | 20,000 | – | – |
|
5
American International
AIG
$45.1B
| $1.92M | 8.57% | 69,681 | – | – |
|